Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Tyrosine Kinase Inhibitors
>>
Phase 1
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Fiasp
(fast-acting insulin aspart) / Novo Nordisk
PD 360324
/ Pfizer
AC430
/ Daiichi Sankyo
PLX5622
/ Daiichi Sankyo
Rinvoq
(upadacitinib) / AbbVie
Soliqua 100/33
(lixisenatide/insulin glargine) / Sanofi
Turalio
(pexidartinib) / Daiichi Sankyo
